Skip to content

A pilot clinical trial to evaluate the efficacy of acupuncture therapy and Needle-Embedding acupuncture therapy on Atopic Dermatitis

A pilot clinical trial to evaluate the efficacy of acupuncture therapy and Needle-Embedding acupuncture therapy on Atopic Dermatitis

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CRIS
Registry ID
KCT0003177
Enrollment
14
Registered
2018-09-12
Start date
2018-01-17
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : Acupuncture therapy group : We used acupuncture and the acupuncture was operated once and retained for 20 minutes at the acupuncture point of the bilateral Gokji(L11) Needle-Embedd

Sponsors

DONGSHIN UNIVERSITY SUNCHEON ORIENTAL MEDICINE HOSPITYAL
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Age 20 and older, 50 and younger (excluded age of 50) (2) Meeting the Hanifin and Rajka criteria, with Atopic Dermatitis symptoms appearing constantly for at least 3 months prior to study enrolment (3) SCORing Atopic Dermatitis (SCORAD) index score 10–40 (4) Not taking prescription drugs for AD for at least 1 month prior to enrolment (5)Ability to understand the study protocol and to voluntarily agree to participate (6)Not participating in any other research studies for AD for at least 1 month prior to enrolment.

Exclusion criteria

Exclusion criteria: (1) Severely fluctuating Atopic Dermatitis symptoms (2) Treatments that are not allowed in this study, for example, oral corticosteroids, which may affect the study outcomes (3) Asthma or bronchitis (4) Other disorders that may affect the outcomes, for example, anxiety or depression. (5) those who have a heart disease (such as heart failure, angina pectoris, Myocardial infarction) (6) Conceivable(Fertile) women who are Pregnant, lactating or not using proper method of contraception (7) those who are thought to be unable to participate in the study by the assessment of researchers

Design outcomes

Primary

MeasureTime frame
Severity Scoring of Atopic Dermatitis(SCORAD) Index

Secondary

MeasureTime frame
Transepidermal Water Loss;skin hydration;Dermatology Life Quality Index;Examination of adverse event

Countries

Korea, Republic of

Contacts

Public ContactSooYeon Park

Dongshin University

swallow92@hanmail.net+82-62-350-7616

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026